RSPO3 and cholangiocarcinoma: Our findings revealed that targeted RSPO3 promoter DNA methylation using dCas9DNMT3a enhanced CCA tumorigenicity, while targeted RSPO3 promoter DNA demethylation using dCas9TET1CD inhibited CCA tumorigenicity.